Syntellix sharpens focus on marketing and sales with new board member
The Supervisory Board of Syntellix AG has appointed Oliver Marx to the company's Executive Board with effect from 1 January 2022. The company’s Chief Sales Officer succeeds Prof. Dr. Martin H. Kirschner, whose mandate expired at the end of 2021.
Marx has been working for the company since 2020. His previous assignments include Medartis AG in Basel, where he was Chief Sales Officer and member of the Executive Board and was jointly in charge and responsible for the successful IPO. Overall, he looks back on a successful career of more than 20 years in the med-tech industry, during which he developed, established and restructured international sales organisations in Europe, the US, Latin America, Asia and the Pacific region.
